FindMyKOL
Clinical trialNCT04144335WithdrawnPhase 1/PHASE2Interventional

N-803 Combined With the Broadly Neutralizing Antibodies Plus or Minus haNK Cells for HIV

SponsorUniversity of MinnesotaEnrollment0AIDSAIDS and InfectionsAids/Hiv ProblemHIV InfectionsHIV/AIDSHiv
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

To assess the safety of combination immune therapy in HIV-infected participants whose HIV is controlled with ART, by determining the incidence and severity of adverse events.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • University of California

    San Francisco, California, United States

  • Beth Israel Deaconess Medical Center

    Boston, Massachusetts, United States

  • University of Minnesota Medical Center

    Minneapolis, Minnesota, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

N-803 and bNAbsHaNK™ Cells
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
1 Jan 2020
Primary completion
31 Dec 2020
Completion
31 Dec 2020
Last update posted
22 Oct 2020
Registered enrollment
0
Registry id
NCT04144335
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.